Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model

Improved outcomes for inborn babies with uncomplicated gastroschisis

(2017) B.G. Dalton et al.   JOURNAL OF PEDIATRIC SURGERY

Roles of nitric oxide and intestinal microbiota in the pathogenesis of necrotizing enterocolitis

(2016) Anatoly Grishin et al.   JOURNAL OF PEDIATRIC SURGERY

Abdominal wall regenerative medicine for a large defect using tissue engineering: an experimental study

(2016) Masaya Suzuhigashi et al.   PEDIATRIC SURGERY INTERNATIONAL

Treatment of bowel in experimental gastroschisis with a nitric oxide donor

(2015) Frances L.L. Gonçalves et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9-tetrahydrocannabinol

(2015) Elad Wasserman et al.   Annals of the New York Academy of Sciences

A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial

(2015) Fernando Althabe et al.   LANCET

Influence of nitric oxide synthase or cyclooxygenase inhibitors on cannabinoids activity in streptozotocin-induced neuropathy

(2015) Magdalena Bujalska-Zadrożny et al.   Pharmacological Reports

Psychiatric Adverse Effects of Pediatric Corticosteroid Use

(2014) Linda B. Drozdowicz et al.   MAYO CLINIC PROCEEDINGS

The role of gut-liver axis in the restriction of intrauterine growth in a model of experimental gastroschisis

(2013) Márcia Pereira Bueno et al.   Acta Cirurgica Brasileira

Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats

(2013) Matheus Perez et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview

(2012) Giuseppe Esposito et al.   PHYTOTHERAPY RESEARCH

Exogenous glucocorticoids and adverse cerebral effects in children

(2011) Sara K. Damsted et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents

(2011) X.-H. Lin et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis

(2011) Daniele De Filippis et al.   PLoS One

Hydrogel protection: a novel approach to reduce bowel inflammation in experimental gastroschisis

(2009) Frances Lilian Lanhellas Gonçalves et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis

(2009) Francesca Borrelli et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Cannabidiol, extracted fromCannabis sativa, selectively inhibits inflammatory hypermotility in mice

(2008) R Capasso et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

(2008) Antonio Waldo Zuardi   REVISTA BRASILEIRA DE PSIQUIATRIA

Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression

(2007) G Esposito et al.   BRITISH JOURNAL OF PHARMACOLOGY